Article
Early EGFR Inhibition Triggers Actionable Tumor and Microenvironmental Remodeling in Lung Cancer.
Cancer research communications - 1 Aug 2026
Tan Aaron C, Yeo Jia Chi, Alvarez Jacob J S, Pang Mengyuan, Guo Yu Amanda, Hoo Regina, Takano Angela M, Ong Boon-Hean, Goh Denise, Yeong Joe, Wu Zhengwei, Yuan Ju, Shathishwaran S, Sim Ngak Leng, Chua Khi Pin, Tam Wai Leong, Wang Lan Ying, Lau Dawn P X, Saw Stephanie P, Jain Amit, Lai Gillianne G, Tan Wan Ling, Ang Mei Kim, Ng Quan Sing, Kanesvaran Ravindran, Lim Darren W, Skanderup Anders J, Tan Daniel S
Abstract excerpt
PURPOSE: Despite widespread use of targeted therapies, little is known about how tumors and their microenvironment respond in the earliest phases of treatment and whether these early changes reveal new therapeutic opportunities. In this study, we investigated how short-term epidermal growth factor receptor (EGFR) inhibition reshapes tumor biology and the tumor microenvironment using comprehensive multiregion and...
Topics
Join the communities discussing this publication.
